Low-molecular weight heparins in pregnancy

Medicina Clinica

Volumn 118, Issue 16, 2002, Pages 634-635

  Aguilera, Cristina ^a   Vallano, Antonio ^a  

^a HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANTICOAGULANT AGENT; ENOXAPARIN; HEPARIN; LOW MOLECULAR WEIGHT HEPARIN;

ARTERY EMBOLISM; ARTICLE; BLEEDING; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; FETUS MALFORMATION; HUMAN; PREGNANCY; SKIN ALLERGY; THROMBOCYTOPENIA; THROMBOEMBOLISM; VEIN THROMBOSIS; PREGNANCY COMPLICATION;

ANTICOAGULANTS; FEMALE; HEPARIN, LOW-MOLECULAR-WEIGHT; HUMANS; PREGNANCY; PREGNANCY COMPLICATIONS, HEMATOLOGIC; VENOUS THROMBOSIS;

EID: 0037018728     PISSN: 00257753     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0025-7753(02)72474-3     Document Type: Article

References (13)

1. Thrombosis in pregnancy: Maternal and fetal issues
2. Safety of witholding heparin in pregnant women with a history of venous thromboembolism
3. Outcome of pregnancy in women with valve protheses
4. Use of antithrombotic agents during pregnancy
5. Low-molecular-weight heparins in pregnancy
6. Safety of low-molecular-weight in pregnancy: A systematic review
7. Low molecular weight heparin use during pregnancy: Issues of safety and practicality
8. Thromboprophylaxis with low molecular weight heparin (dalteparin) in pregnancy
9. Thromboembolism in pregnant women with mechanical prosthetic heart valves anticoagulated with low molecular weight heparins
10. Enoxaparin treatment in women with mechanical heart valves during pregnancy
11. Bleeding complications associated with low molecular weight heparin prophylaxis during pregnancy
12. Fármacos que alteran la hemostasia y técnicas regionales anestésicas: Recomendaciones de seguridad. Foro de consenso
13. Gestational outcome in thrombophilic women with recurrent pregnancy loss treated by enoxaparin